Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis

International Journal of Gynecological Cancer

Volumn 16, Issue 5, 2006, Pages 1868-1872

  Yang, Y X ^a   Yang, A H ^a   Yang, Z J ^b,c   Wang, Z R ^a   Xia, X H ^a  

^a LANZHOU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Shanghai Jiaotong University ^*  (China)

Author keywords

Carcinogenesis; Cervical cancer; Gene expression; TSLC1

Indexed keywords

ARTICLE; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR IN LUNG CANCER 1 GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

CARCINOMA; CERVIX UTERI; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULINS; MEMBRANE PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 33749129577     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00656.x     Document Type: Article

References (30)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:72-81.
3. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
4. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
5. Pilch H, Gunzel S, Schaffer U et al. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer 2001;11:39-48.
6. Cuzick J, Szarewski A, Cubie H et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-6.
7. Munoz N, Bosch FX, De Sanjose S et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
8. Ho G, Bierman R, Deardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
9. Connolly DC, Greenspan DL, Wu R et al. Loss of FHIT expression in invasive cervical carcinomas and intraepithelial lesion associated with invasive disease. Clin Cancer Res 2000;6:3505-10.
10. Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ. HPV-mediated transformation of the anogenital tract. J Clin Virol 2005;32(Suppl. 1):S25-33.
11. Pletcher MT, Nobukuni T, Fukuhara H et al. Identification of tumor suppressor candidate genes by physical and sequence mapping of the TSLC1 region of human chromosome 11q23. Gene 2001;273:181-9.
12. Kuramochi M, Fukunara H, Nobukuni T et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001;27:427-30.
13. Murakami Y. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene 2002;21:6936-48.
14. Masuda M, Yageta M, Fukuhara H et al. The tumor suppressor protein TSLC1 is involved in cell-cell adhesion. J Biol Chem 2002;227:31014-9.
15. Fukuhara H, Kuramochi M, Nobukuni T et al. Isolation of the TSLL1 and TSLC2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins. Oncogene 2001;20:5401-7.
16. Murakami Y. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 2005;96:543-52.
17. Steenbergen RD, Kramer D, Braakhuis BJ et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004;96:294-305.
18. Kreuzer KA, Lass U, Landt O et al. Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of b-actin transcripts as quantitative reference. Clin Chem 1999;45:297-300.
19. Bernard PS, Wittwer CT. Real-time PCR technology for cancer diagnostics. Clin Chem 2002;48:1178-85.
20. Shah KV, Kessis TD, Shah F, Gupta JW, Shibata DK, Jones RW. Human papillomavirus investigation of patients with cervical intraepithelial neoplasia 3, some of whom progressed to invasive cancer. Int J Gynecol Pathol 1998;15:127-30.
21. Stoler MH. Human papillomavirus and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol 2000;19:16-28.
22. Bollen L, Tjong-A-Hung SP, van der Velden J et al. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 1999;72:199-201.
23. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Kinger HP. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus tumor status. Cancer Res 1996;56:197-205.
24. Rader JS, Kamarasova T, Huettner PC, Li L, Li Y, Gerhard DS. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene 1997;13:2737-41.
25. Narayan G, Arias-Pulido H, Koul S et al. Frequent promoter methylation of CDH1, DAPK, RARB and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2003;2:24.
26. Widschwendter A, Muller HM, Fiegl H et al. DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res 2004;10:565-71.
27. Ito T, Shimada Y, Hashimoto Y et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 2003;63:6320-26.
28. Goto A, Niki T, Chi-Pin L et al. Loss of TSLC1 expression in lung adenocarcinoma: relationships with histological subtypes, sex and prognostic significance. Cancer Sci 2005;96:480-6.
29. Surace EI, Lusis E, Murakami Y, Scheithauter BW, Perry A, Gutmann DH. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. J neuropathol Exp Neurol 2004;63:1015-27.
30. Uchino K, Ito A, Wakayama T et al. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Cancer 2003;98:1002-7.